Literature DB >> 33557031

Adiposity in Depression or Depression in Adiposity? The Role of Immune-Inflammatory-Microbial Overlap.

Oliwia Gawlik-Kotelnicka1, Dominik Strzelecki1.   

Abstract

Some of the most common and debilitating conditions are metabolic disorders (metabolic syndrome and non-alcoholic fatty liver disease) and depression. These conditions are also exacerbated by the fact that they often co-occur. Although the exact mechanisms underlying such relationships are poorly known, antipsychotic medication and antidepressant use, diet and physical activity, and lifestyle factors are believed to play a role; however, their high co-occurrence rate suggests a possible pathophysiological overlap. This paper reviews several possible bases for this overlap, including hypothalamic-pituitary-adrenal axis dysregulation, immune alterations with chronic inflammation, and oxidative stress. While it is entirely possible that changes in the microbiota may play a role in each of them, interventions based on the implementation of dietary and other lifestyle changes, supplementation with prebiotics or probiotics and faecal microbiota transplantation have failed to achieve conclusive results. A better characterization of the above associations may allow a more targeted approach to the treatment of both depressive and metabolic disorders. The paper also presents several practical applications for future studies.

Entities:  

Keywords:  depression; hypothalamic-pituitary-adrenal axis; inflammation; metabolic syndrome; microbiota; non-alcoholic fatty liver disease; oxidative stress

Year:  2021        PMID: 33557031      PMCID: PMC7913759          DOI: 10.3390/life11020117

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  108 in total

Review 1.  The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

Authors:  Roger S McIntyre; Ka Young Park; Candy W Y Law; Farah Sultan; Amanda Adams; Maria Teresa Lourenco; Aaron K S Lo; Joanna K Soczynska; Hanna Woldeyohannes; Mohammad Alsuwaidan; Jinju Yoon; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

Review 2.  Depression.

Authors:  Gin S Malhi; J John Mann
Journal:  Lancet       Date:  2018-11-02       Impact factor: 79.321

3.  Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial.

Authors:  Asma Kazemi; Ahmad Ali Noorbala; Kamal Azam; Mohammad Hadi Eskandari; Kurosh Djafarian
Journal:  Clin Nutr       Date:  2018-04-24       Impact factor: 7.324

Review 4.  Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder.

Authors:  Kenny L Chan; Flurin Cathomas; Scott J Russo
Journal:  Physiology (Bethesda)       Date:  2019-03-01

Review 5.  The role of prebiotics in cognition, anxiety, and depression.

Authors:  Igor Henrique R Paiva; Eduardo Duarte-Silva; Christina Alves Peixoto
Journal:  Eur Neuropsychopharmacol       Date:  2020-03-30       Impact factor: 4.600

Review 6.  The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota?

Authors:  Błażej Misiak; Igor Łoniewski; Wojciech Marlicz; Dorota Frydecka; Agata Szulc; Leszek Rudzki; Jerzy Samochowiec
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-04-23       Impact factor: 5.067

Review 7.  Brain-gut-microbiota axis: challenges for translation in psychiatry.

Authors:  John R Kelly; Gerard Clarke; John F Cryan; Timothy G Dinan
Journal:  Ann Epidemiol       Date:  2016-03-08       Impact factor: 3.797

Review 8.  Oxidative Stress and the Microbiota-Gut-Brain Axis.

Authors:  Laura Dumitrescu; Iulia Popescu-Olaru; Liviu Cozma; Delia Tulbă; Mihail Eugen Hinescu; Laura Cristina Ceafalan; Mihaela Gherghiceanu; Bogdan Ovidiu Popescu
Journal:  Oxid Med Cell Longev       Date:  2018-12-09       Impact factor: 6.543

9.  Stress-induced activation of brown adipose tissue prevents obesity in conditions of low adaptive thermogenesis.

Authors:  Maria Razzoli; Andrea Frontini; Allison Gurney; Eleonora Mondini; Cankut Cubuk; Liora S Katz; Cheryl Cero; Patrick J Bolan; Joaquin Dopazo; Antonio Vidal-Puig; Saverio Cinti; Alessandro Bartolomucci
Journal:  Mol Metab       Date:  2015-11-11       Impact factor: 7.422

Review 10.  The Global Epidemic of the Metabolic Syndrome.

Authors:  Mohammad G Saklayen
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

View more
  4 in total

1.  Non-melancholic depressive symptoms are associated with above average fat mass index in the Helsinki birth cohort study.

Authors:  Mia D Eriksson; Johan G Eriksson; Päivi Korhonen; Minna K Salonen; Tuija M Mikkola; Eero Kajantie; Niko S Wasenius; Mikaela von Bonsdorff; Hannu Kautiainen; Merja K Laine
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

Review 2.  Probiotics as a Treatment for "Metabolic Depression"? A Rationale for Future Studies.

Authors:  Oliwia Gawlik-Kotelnicka; Dominik Strzelecki
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-20

3.  Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease.

Authors:  Jieling Xiao; Lincoln Kai En Lim; Cheng Han Ng; Darren Jun Hao Tan; Wen Hui Lim; Cyrus S H Ho; Eunice Xiang Xuan Tan; Arun J Sanyal; Mark D Muthiah
Journal:  Front Med (Lausanne)       Date:  2021-06-30

4.  The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation, and Oxidative Stress Parameters and Fecal Microbiota in Patients with Depression Depending on Metabolic Syndrome Comorbidity-PRO-DEMET Randomized Study Protocol.

Authors:  Oliwia Gawlik-Kotelnicka; Anna Skowrońska; Aleksandra Margulska; Karolina H Czarnecka-Chrebelska; Igor Łoniewski; Karolina Skonieczna-Żydecka; Dominik Strzelecki
Journal:  J Clin Med       Date:  2021-03-24       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.